Skip to main content
logo
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
267.47
-15.68 (-5.54%)
At close: Jul 17, 2026, 4:00 PM EDT
267.69
+0.22 (0.08%)
After-hours: Jul 17, 2026, 5:45 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
35,71152,63930,42424,07829,45120,381
Market Cap Growth
-14.96%73.02%26.36%-18.24%44.51%34.69%
Enterprise Value
35,87951,00929,02622,94428,57918,943
Last Close Price
267.47397.65235.31191.41237.65169.58
PE Ratio
71.68170.67----
Forward PE
34.9960.03----
PS Ratio
8.3814.1713.5313.1728.3924.14
PB Ratio
35.1466.70453.50-109.13-186.1334.65
P/TBV Ratio
33.7367.86447.73--34.15
P/FCF Ratio
55.83113.11-574.04--
P/OCF Ratio
50.24100.44-231.18--
EV/Sales Ratio
8.3713.7312.9112.5527.5522.44
EV/EBITDA Ratio
44.4691.54----
EV/EBIT Ratio
47.70101.70----
EV/FCF Ratio
55.77109.61-547.01--
Debt / Equity Ratio
1.141.5618.69-5.73-8.081.63
Debt / EBITDA Ratio
1.582.29----
Debt / FCF Ratio
1.982.75-31.12--
Net Debt / Equity Ratio
-1.61-2.07-20.845.145.51-2.44
Net Debt / EBITDA Ratio
-2.15-2.9211.634.971.182.17
Net Debt / FCF Ratio
-2.70-3.5032.84-27.031.422.00
Asset Turnover
0.850.810.560.500.290.24
Inventory Turnover
9.868.463.862.851.571.73
Quick Ratio
2.882.512.612.863.163.79
Current Ratio
3.132.762.783.083.514.04
Return on Equity (ROE)
61.91%73.28%362.29%232.40%-526.14%-106.31%
Return on Assets (ROA)
14.67%10.58%-3.23%-7.77%-21.92%-20.12%
Return on Invested Capital (ROIC)
---17.04%-10.16%-81.71%-
Return on Capital Employed (ROCE)
20.66%15.31%-5.98%-10.01%-27.42%-24.57%
Earnings Yield
1.50%0.59%----
FCF Yield
1.79%0.88%-0.17%--
Buyback Yield / Dilution
-6.45%-5.51%-2.20%-2.64%-2.73%-3.01%
Total Shareholder Return
-6.45%-5.51%-2.20%-2.64%-2.73%-3.01%
SEC Filings: 10-K · 10-Q